The independent source for health policy research, polling, and news.
2,241 - 2,260 of 18,903 Results
The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act of 2024 is named after a New York physician who died by suicide in 2020, Modern Healthcare reports. The bill would authorize five years of grant programs. Other news is on the Affordable Care Act, doxycycline, and more.
After a week of tallying ballots, the votes in favor of Proposition 1 were maintaining a slim lead. The measure would vastly increase the number of treatment beds and supportive housing facilities. Other news is from Arkansas, Texas, Missouri, West Virginia, and Florida.
President Joe Biden will hold more than 13 news conferences through Friday across key swing states, all focused on protecting the entitlement programs, the Hill reports. Meanwhile, Politico reports that the CDC might also shrink if former President Donald Trump is elected.
The Department of Veterans Affairs had faced legal challenges alleging its IVF coverage was discriminatory. Meanwhile, in Minnesota, Democratic lawmakers push to boost coverage rules and protect access to IVF treatments.
Johns Hopkins, Henry Ford Health, and the American Medical Association were among groups who signed a letter sent to congressional leaders Monday. Other news is on Steward Health, the VA's EHR system, a nurse's strike in Chicago, and more.
New York Attorney General Letitia James had accused Walgreens of inflating prices after the Abbott Labs recall led to a formula shortage. Also in the news: A child died from flu in Michigan; 10 states sue over a "sham" women's cancer charity; and more.
The settlement says teachers and students can discuss LGBTQ+ matters and "largely" cancels impacts of signature legislation from Republican Gov. Ron DeSantis, the Washington Post says. His office noted the law is still in effect.
The White House released its proposed budget blueprint for FY2025 on Monday. Included health care provisions would: increase HHS discretionary spending by 1.7%; focus on Medicare solvency; invest in federal responses to cyberattacks; address coverage for people in states that did not expand Medicaid; and other measures.
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
Though the FDA approved the drug less than two years ago, Amylyx's ALS drug has now failed a large clinical trial. Separately, the FDA is delaying approval for an experimental Alzheimer's drug so it can examine its effectiveness.
A report says doctors are complaining that insurers' delays and denials are impacting patients who need a machine's help to breathe. Also in the news: UnitedHealth quietly bought lots of outpatient centers, for the most part without announcing it had done so.
Three years after adopting the most liberal drug laws in the nation, a new Oregon bill would reintroduce criminal penalties for drug use, while also allowing officials some latitude in pushing for treatment or jail for offenders. Other regional public health news is reported from Maryland, California, Colorado, and Texas.
The Centers for Medicare and Medicaid Services announced Saturday that it will provide advances to hospital, health groups, and other medical providers that have been financially impacted by delayed payments from Change Healthcare after its system outage caused by a ransomware attack. HHS is also urging UnitedHealth, the parent company, to expedite payments.
As part of President Joe Biden's push to expand his cancer moonshot program, more than six large insurers have agreed to cover services offered by cancer navigators who help patients through the complicated medical treatment options and process.
On this episode of “An Arm and a Leg,” host Dan Weissmann breaks down the complicated and expensive world of Medicare with practical tips to pick the right plan and avoid penalties.
President Joe Biden used his roughly 68-minute address to Congress to counter lackluster public approval ratings and draw clear contrasts between his administration’s policies and those of Donald Trump and some congressional Republicans. Abortion and health care were in the spotlight.
Drugmaker Eli Lilly, which produces weight-loss drug Zepbound, is criticizing people who prescribe or take such drugs without an obesity diagnosis.
A study finds that dropped calls and long wait times are "hindering" access to health care for people with Medicaid coverage. Other regional health news comes from Minnesota, Kentucky, and California.
The Senate approved legislation by a 69-30 vote Thursday that would expand the Radiation Exposure Compensation Act to cover more Americans who were likely sickened by radiation exposure due to government activities. Other news from Capitol Hill focuses on health measure expiring at the end of this year and WIC funding.
Its e-prescribing platform is up and running after a Feb. 21 cyberattack pushed it offline. The company hopes to reactivate two other platforms — for electronic payments and medical claims — late next week.
© 2026 KFF